It cannot be used with any other offer. According to Dr Vegan, as we age, natural collagen production drops, which can lead to wrinkles, sagging and fragility. Women experience an even sharper decline ...

Persistent ear itching can signal various issues, from simple earwax buildup and infections to skin conditions like eczema ...

Early childhood stress, especially before age 1, significantly increases psoriasis risk, with an odds ratio of 4.19. The study involved over 16,000 children, using data from the All Babies in ...

PSORIASIS is no longer regarded as a single, uniform condition. Once classified primarily by visible lesions or severity, it ...

Psoriasis is not just a skin issue—it reflects a deeper systemic imbalance involving immune dysregulation, inflammation and ...

Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...

Give your skin the natural care it deserves with Thena Natural Wellness's ultimate Skin Healing Cream! Our unique formula is ...

Please provide your email address to receive an email when new articles are posted on . Patients in a 16-week Mediterranean diet program saw improvements in their psoriasis compared with those on a ...

The U.S. Food and Drug Administration has approved Johnson & Johnson's Tremfya (guselkumab) for the treatment of plaque psoriasis and active psoriatic arthritis in children 6 years of age and older.

Tremfya is the first IL-23 inhibitor approved for pediatric plaque psoriasis and psoriatic arthritis, based on the PROTOSTAR trial's positive results. The PROTOSTAR trial demonstrated significant skin ...

Over 60 million people worldwide are affected by psoriasis, a chronic inflammatory skin disorder that causes red, scaly patches and persistent itching. A new study has found that following a ...

Sept 25 (Reuters) - Bristol Myers Squibb (BMY.N), opens new tab said on Thursday it will sell its psoriasis drug Sotyktu directly to cash-paying U.S. patients at a more than 80% discount to its list ...